Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients.
Saved in:
| Title: | Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. |
|---|---|
| Authors: | Legge F; Gynecologic Oncology Unit, Catholic University of Campobasso, Italy., Paglia A, D'Asta M, Fuoco G, Scambia G, Ferrandina G |
| Source: | BMC cancer [BMC Cancer] 2011 May 31; Vol. 11, pp. 214. Date of Electronic Publication: 2011 May 31. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 21627839 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Legge+F%22">Legge F</searchLink>; Gynecologic Oncology Unit, Catholic University of Campobasso, Italy.<br /><searchLink fieldCode="AU" term="%22Paglia+A%22">Paglia A</searchLink><br /><searchLink fieldCode="AU" term="%22D'Asta+M%22">D'Asta M</searchLink><br /><searchLink fieldCode="AU" term="%22Fuoco+G%22">Fuoco G</searchLink><br /><searchLink fieldCode="AU" term="%22Scambia+G%22">Scambia G</searchLink><br /><searchLink fieldCode="AU" term="%22Ferrandina+G%22">Ferrandina G</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2011 May 31; Vol. 11, pp. 214. <i>Date of Electronic Publication: </i>2011 May 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21627839 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/1471-2407-11-214 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 214 Titles: – TitleFull: Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Legge F – PersonEntity: Name: NameFull: Paglia A – PersonEntity: Name: NameFull: D'Asta M – PersonEntity: Name: NameFull: Fuoco G – PersonEntity: Name: NameFull: Scambia G – PersonEntity: Name: NameFull: Ferrandina G IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 05 Text: 2011 May 31 Type: published Y: 2011 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 11 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |
